Gary L Darmstadt1, Saifuddin Ahmed, A S M Nawshad Uddin Ahmed, Samir K Saha. 1. From the *Global Development Division, Bill and Melinda Gates Foundation, Seattle, WA; †Department of Population, Family and Reproductive Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; ‡Department of Neonatology; and §Department of Microbiology,Dhaka Shishu (Children) Hospital, Dhaka, Bangladesh.
Abstract
BACKGROUND: Topical applications of emollients such as sunflower seed oil and Aquaphor have been shown to reduce the incidence of bloodstream infections and mortality of preterm infants in resource-poor settings. The causal mechanism for prevention of infection through cutaneous portals of entry is not well understood. METHODS: We examined the relationship between skin condition score as a measure of skin barrier integrity and risk for bloodstream infection, and the effect of emollients on that relationship. Data for this study come from a randomized controlled trial of the impact of topical emollient therapy on nosocomial infections in 491 preterm infants <33 weeks gestational age at Dhaka Shishu Hospital, Bangladesh. Latent growth trajectory model with random-coefficient and multivariable logistic regression were utilized. RESULTS:Rate of deterioration of skin condition was significantly lower (P < 0.05) in both emollient arms compared with the untreated control group. Adjusted odds ratio of skin score for infection was 1.32 (95% confidence interval: 1.06-1.65). Emollients reduced the incidence of infection only when the skin had no signs of deterioration [Aquaphor incidence rate ratio: 0.43 (95% confidence interval: 0.19-0.97) and sunflower seed oil incidence rate ratio: 0.46 (95% confidence interval: 0.21-0.99)]. CONCLUSION: Skin condition deteriorated progressively after birth and compromised skin condition increased the risk of infection. Emollients preserved skin integrity and thus prevented infection in preterm neonates. To optimize benefits of emollients for the prevention of bloodstream infection, use of emollients should begin immediately after birth when the skin is still intact.
RCT Entities:
BACKGROUND: Topical applications of emollients such as sunflower seed oil and Aquaphor have been shown to reduce the incidence of bloodstream infections and mortality of preterm infants in resource-poor settings. The causal mechanism for prevention of infection through cutaneous portals of entry is not well understood. METHODS: We examined the relationship between skin condition score as a measure of skin barrier integrity and risk for bloodstream infection, and the effect of emollients on that relationship. Data for this study come from a randomized controlled trial of the impact of topical emollient therapy on nosocomial infections in 491 preterm infants <33 weeks gestational age at Dhaka Shishu Hospital, Bangladesh. Latent growth trajectory model with random-coefficient and multivariable logistic regression were utilized. RESULTS: Rate of deterioration of skin condition was significantly lower (P < 0.05) in both emollient arms compared with the untreated control group. Adjusted odds ratio of skin score for infection was 1.32 (95% confidence interval: 1.06-1.65). Emollients reduced the incidence of infection only when the skin had no signs of deterioration [Aquaphor incidence rate ratio: 0.43 (95% confidence interval: 0.19-0.97) and sunflower seed oil incidence rate ratio: 0.46 (95% confidence interval: 0.21-0.99)]. CONCLUSION: Skin condition deteriorated progressively after birth and compromised skin condition increased the risk of infection. Emollients preserved skin integrity and thus prevented infection in preterm neonates. To optimize benefits of emollients for the prevention of bloodstream infection, use of emollients should begin immediately after birth when the skin is still intact.
Authors: Laurent Renesme; A Allen; F Audeoud; C Bouvard; A Brandicourt; C Casper; L Cayemaex; H Denoual; M A Duboz; A Evrard; C Fichtner; C J Fischer-Fumeaux; L Girard; F Gonnaud; D Haumont; P Hüppi; N Knezovic; E Laprugne-Garcia; S Legouais; F Mons; V Pelofy; J C Picaud; V Pierrat; P Pladys; A Reynaud; G Souet; G Thiriez; P Tourneux; M Touzet; P Truffert; C Zaoui; E Zana-Taieb; C Zores; J Sizun; P Kuhn Journal: Eur J Pediatr Date: 2019-08-28 Impact factor: 3.183
Authors: Maeve M Kelleher; Suzie Cro; Victoria Cornelius; Karin C Lodrup Carlsen; Håvard O Skjerven; Eva M Rehbinder; Adrian J Lowe; Eishika Dissanayake; Naoki Shimojo; Kaori Yonezawa; Yukihiro Ohya; Kiwako Yamamoto-Hanada; Kumiko Morita; Emma Axon; Christian Surber; Michael Cork; Alison Cooke; Lien Tran; Eleanor Van Vogt; Jochen Schmitt; Stephan Weidinger; Danielle McClanahan; Eric Simpson; Lelia Duley; Lisa M Askie; Joanne R Chalmers; Hywel C Williams; Robert J Boyle Journal: Cochrane Database Syst Rev Date: 2021-02-05
Authors: A Summers; M O Visscher; S K Khatry; J B Sherchand; S C LeClerq; J Katz; J M Tielsch; L C Mullany Journal: J Perinatol Date: 2017-11-09 Impact factor: 2.521
Authors: K M Shahunja; Tahmeed Ahmed; Md Iqbal Hossain; Mustafa Mahfuz; Lindsay Kendall; Xinyi Zhu; Krishan Singh; Jonathan M Crowther; Sunita Singh; Rachel A Gibson; Gary L Darmstadt Journal: J Glob Health Date: 2020-06 Impact factor: 4.413
Authors: Aimee Summers; Marty O Visscher; Subarna K Khatry; Jeevan B Sherchand; Steven C LeClerq; Joanne Katz; James M Tielsch; Luke C Mullany Journal: BMC Pediatr Date: 2019-12-23 Impact factor: 2.125
Authors: K M Shahunja; Daniel C Sévin; Lindsay Kendall; Tahmeed Ahmed; Md Iqbal Hossain; Mustafa Mahfuz; Xinyi Zhu; Krishan Singh; Sunita Singh; Jonathan M Crowther; Rachel A Gibson; Gary L Darmstadt Journal: Nutr J Date: 2021-06-06 Impact factor: 3.271
Authors: Martin Glatz; Jay-Hyun Jo; Elizabeth A Kennedy; Eric C Polley; Julia A Segre; Eric L Simpson; Heidi H Kong Journal: PLoS One Date: 2018-02-28 Impact factor: 3.240